A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)
Public ClinicalTrials.gov record NCT02215252. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Double Blind Placebo And Active Controlled Parallel Group Phase 2 Study To Evaluate PF-05089771 As A Monotherapy And As An Add-on To Pregabalin For The Treatment Of Painful Diabetic Peripheral Neuropathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of PF-05089771 as a monotherapy and as an add-on to pregabalin for the treatment of painful diabetic peripheral neuropathy (DPN)
Study identification
- NCT ID
- NCT02215252
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 141 participants
Conditions and interventions
Conditions
Interventions
- PF-05089771 150 mg Drug
- Matched placebo for PF-05089771 150 mg and pregabalin 300 mg Drug
- Pregabalin 300 mg Drug
- PF-05089771 150 mg + Pregabalin 300 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 10, 2014 (Actual)
- Primary completion
- Jul 15, 2015 (Actual)
- Completion
- Sep 28, 2015 (Actual)
- Last update posted
- May 5, 2017
2014 – 2015
United States locations
- U.S. sites
- 32
- U.S. states
- 13
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Consortium Arizona | Phoenix | Arizona | 85003 | — |
| Arizona Research Center | Phoenix | Arizona | 85023 | — |
| Neuro-Pain Medical Center | Fresno | California | 93710 | — |
| Meridien Research | Bradenton | Florida | 34208 | — |
| PAB Clinical Research | Brandon | Florida | 33511 | — |
| Pulmonary Associates of Brandon (PAB) | Brandon | Florida | 33511 | — |
| Meridien Research | Brooksville | Florida | 34601 | — |
| Clinical Physiology Associates | Fort Myers | Florida | 33912 | — |
| MD Clinical | Hallandale | Florida | 33009 | — |
| Meridien Research | Lakeland | Florida | 33805 | — |
| Family Care Specialists | Ocala | Florida | 34471 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Oviedo Medical Research, LLC | Oviedo | Florida | 32765 | — |
| Meridien Research | St. Petersburg | Florida | 33709 | — |
| Meridien Research | Tampa | Florida | 33634 | — |
| Metabolic Research Institute, Inc | West Palm Beach | Florida | 33401 | — |
| Columbus Regional Research Institute | Columbus | Georgia | 31904 | — |
| Clinical Research Advantage, Inc | Evansville | Indiana | 47714 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Novex Clinical Research, LLC | New Bedford | Massachusetts | 02740 | — |
| Beacon Clinical Research, LLC | Quincy | Massachusetts | 02169 | — |
| Michigan Head Pain and Neurological Institute | Ann Arbor | Michigan | 48104 | — |
| Clinical Research Consortium | Las Vegas | Nevada | 89119 | — |
| The Medical Research Network, LLC | New York | New York | 10128 | — |
| New Phase Research and Development | Knoxville | Tennessee | 37919 | — |
| Internal Medicine Associates | Tullahoma | Tennessee | 37388 | — |
| Trinity Clinical Research, LLC | Tullahoma | Tennessee | 37388 | — |
| KRK Medical Research | Arlington | Texas | 76012 | — |
| Nerve and Muscle Center of Texas | Houston | Texas | 77030 | — |
| National Clinical Research - Norfolk, Inc | Norfolk | Virginia | 23502 | — |
| Eastern Virginia Medical School | Norfolk | Virginia | 23510 | — |
| Rainier Clinical Research Center, Inc | Renton | Washington | 98057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02215252, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 5, 2017 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02215252 live on ClinicalTrials.gov.